Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab.
Medkour
F
F
Babai
S
S
Chanteloup
E
E
Buffard
V
V
Delchier
J-C
JC
Le-Louet
H
H
D000328:Adult; D000505:Alopecia / Q000139:chemically induced*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D008297:Male; D011565:Psoriasis / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab